Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

HFXI

IQ 50 Percent Hedged FTSE International ETF (HFXI)

Rating:60Neutral
Price Target:$39.00â–²(6.53% Upside)

HFXI’s rating suggests it is a solid but not top-tier international ETF, with its quality driven largely by strong holdings in companies like Novartis, HSBC, and AstraZeneca, which show robust financial performance, positive earnings outlooks, and supportive technical trends. Additional support comes from names like ASML, Roche, Shell, Nestlé, and Mitsubishi UFJ, though some face valuation concerns, potential overbought conditions, or cash flow and leverage risks that slightly weigh on the fund’s overall appeal. The main risk factor is its exposure to several large, globally diversified firms where high valuations and sector-specific challenges (especially in healthcare and financials) could increase volatility.

Positive Factors
Strong Year-to-Date PerformanceThe ETF has delivered strong gains so far this year, showing solid overall momentum despite recent short-term pullbacks.
Leading Semiconductor and Tech HoldingsTop positions like Samsung Electronics, SK hynix, ASML, and SAP have shown strong performance, helping drive the fund’s returns.
Broad Global and Sector DiversificationThe fund spreads investments across many countries and industries, which helps reduce the impact of problems in any single market or sector.
Negative Factors
Recent Short-Term WeaknessThe ETF has seen weak performance over the last month and quarter, which may signal near-term volatility or pressure on international markets.
Heavy Exposure to Japan and a Few CountriesA large share of assets is concentrated in Japan and several other key markets, increasing the fund’s sensitivity to economic or political issues in those regions.
Mixed Results Among Defensive HoldingsSome major defensive stocks like Nestlé and AstraZeneca have shown only flat or weak performance, which can limit the fund’s stability during market stress.

HFXI vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%30%SPY+14.55%HFXI+20.26%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
2.55B
Region
Developed Markets
Expense Ratio
0.20%
Beta
0.80
Issuer
NYLIM
Inception Date
Jul 22, 2015
Dividend Yield
3.19%
Asset Class
Equity
Index Tracked
FTSE Developed ex North America 50% Hedged to USD Index

HFXI Summary

HFXI is an exchange-traded fund that follows the FTSE Developed ex North America 50% Hedged to USD Index, giving you broad exposure to stocks from developed countries outside the U.S. and Canada, with half of the currency risk reduced. It owns many well-known international companies such as Samsung Electronics, Nestlé, and Shell, across sectors like technology, finance, and health care. Someone might invest in HFXI to diversify beyond the U.S. market while still limiting some of the impact of foreign currency swings. A key risk is that international stock prices can still go up and down significantly with global markets.

How much will it cost me?

HFXI has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 invested. This cost is slightly higher than the cheapest index ETFs because it uses a partial currency hedge and a more specialized strategy, but it’s still relatively low compared with many actively managed funds.

What would affect this ETF?

HFXI could benefit if developed markets outside North America grow steadily, especially in technology, financials, and health care, and if currency swings remain moderate so its 50% hedge helps smooth returns without losing too much upside. On the downside, global slowdowns, banking or energy sector stress, stricter regulations in key countries, or sharp moves in foreign currencies against the U.S. dollar could hurt performance even with partial currency protection.

HFXI Top 10 Holdings

HFXI leans heavily on global blue chips, with a clear tilt toward overseas tech and healthcare leaders. Samsung Electronics is a steady anchor, while SK hynix and ASML have been more mixed lately, occasionally losing steam and dampening the fund’s momentum despite their long-term semiconductor appeal. On the brighter side, defensive names like Nestlé and pharma giants Novartis and AstraZeneca are quietly rising, helping smooth out volatility. Financials such as HSBC and Mitsubishi UFJ are more of a mixed bag, leaving performance driven largely by non-U.S. Europe and Asia stalwarts.

HFXI top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
KR:005930KR:005930Samsung Electronics2.83%$70.62MKRW 1315.56T100.39%――
NL:ASMLNL:ASMLASML Holding NV2.33%$58.16MEUR 536.23B51.88%76Outperform
KR:000660KR:000660SK hynix Inc.2.14%$53.33MKRW 930.76T103.24%――
RHHVFRHHVFRoche Holding AG――――73Outperform
CH:NOVNCH:NOVNNovartis AG1.15%$28.77MCHF 242.99B26.78%80Outperform
GB:HSBAGB:HSBAHSBC Holdings1.20%$29.91MGBP 232.19B20.93%80Outperform
GB:SHELGB:SHELShell (UK)1.11%$27.59MGBP 207.92B30.08%73Outperform
AZNAZNAstraZeneca――――80Outperform
CH:NESNCH:NESNNestlé SA1.02%$25.48MCHF 220.98B8.18%71Outperform
DE:SAPDE:SAPSAP SE0.90%$22.46MEUR 246.30B-2.13%66Neutral

HFXI Technical Analysis

Technical Analysis SentimentPositive
Last Price36.61

Price Trends

50DMA36.99Negative
100DMA37.29Negative
200DMA36.32Positive

Market Momentum

MACD-0.14Negative
RSI49.48Neutral
STOCH70.59Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HFXI, the sentiment is Positive. The current price of 36.61 is above the 20-day moving average (MA) of 36.40, below the 50-day MA of 36.99, and above the 200-day MA of 36.32, indicating a neutral trend. The MACD of -0.14 indicates Negative momentum. The RSI at 49.48 is Neutral, neither overbought nor oversold. The STOCH value of 70.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HFXI.

HFXI Peer Comparison

Comparison Results

HFXI against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
HFXIHFXI$36.61$39.00(6.53% Upside)$2.55B0.20%60Neutral
DBEFDBEF$56.04$66.13(18.01% Upside)$9.51B0.35%65Neutral
BBINBBIN$78.10$92.61(18.58% Upside)$6.59B0.07%66Neutral
EFAVEFAV$96.91$102.08(5.34% Upside)$5.63B0.20%61Neutral
IHDGIHDG$53.10$63.26(19.14% Upside)$2.11B0.58%66Neutral
DDWMDDWM$46.50$53.26(14.54% Upside)$1.45B0.40%64Neutral

Performance Comparison

0%10%20%HFXIDBEFBBINEFAVIHDGDDWMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HFXI and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HFXIIQ 50 Percent Hedged FTSE International ETF36.615.8418.98%
DBEFXtrackers MSCI EAFE Hedged Equity ETF56.049.4720.33%
BBINJPMorgan BetaBuilders International Equity ETF78.109.9814.66%
EFAViShares MSCI EAFE Min Vol Factor ETF96.9114.1217.05%
IHDGWisdomTree International Hedged Quality Dividend Growth Fund53.107.0515.30%
DDWMWisdomTree Dynamic Currency Hedged International Equity Fund46.505.5213.48%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.